GHRH vs GHRP: Growth Hormone Peptide Guide

If you have spent any time reading about growth-hormone peptides, you have run into two acronyms that look similar and are constantly confused: GHRH and GHRP. They describe two different categories of compound that act on the same system by different routes. Understanding the distinction is the key to reading this literature and to understanding why the best-known research pairing, CJC-1295 with Ipamorelin, combines one from each category.

GHRH analogs: the accelerator

GHRH stands for growth-hormone-releasing hormone. The body produces it naturally to signal the pituitary. A GHRH analog is a synthetic peptide that mimics this signal. CJC-1295 is the most studied example. In the No DAC form, it is a modified GHRH fragment used in research precisely because it engages the GHRH pathway in a defined, characterised way. Think of a GHRH analog as pressing on the accelerator of the system’s own signalling.

GHRPs: releasing the brake

GHRP stands for growth-hormone-releasing peptide, a family that also includes ghrelin-mimetic compounds. Ipamorelin is a widely referenced member. GHRPs act through a different receptor than GHRH analogs. Rather than mimicking the releasing hormone directly, they work on a parallel pathway, which is why they are often described as releasing a brake rather than pressing the accelerator.

Why the two categories are studied together

Because GHRH analogs and GHRPs act on two separate mechanisms, researchers frequently study them in combination to observe how the pathways interact. That is the entire logic behind the CJC-1295 and Ipamorelin pairing: one compound from each category, chosen so that the two mechanisms can be examined side by side in the same model. It is the reason the combination is the single most common growth-hormone-peptide search among researchers.

Why the No DAC form comes up

You will often see CJC-1295 specified as No DAC. DAC refers to a drug-affinity-complex modification that extends how long the peptide persists in a system. The No DAC form does not carry that modification, so it is studied when a shorter, more defined signalling window is wanted. It is worth knowing the distinction simply so you order the version your reference literature actually used, since the two are not interchangeable in a study design.

What to verify before you order

With any growth-hormone peptide, identity is everything, because closely related sequences and truncated fragments can look similar on a label but behave differently in a model. Insist on mass-spectrometry confirmation of the sequence, an HPLC purity figure, and a certificate of analysis tied to the specific lot. For a two-peptide pairing, you want that documentation for each compound, not a single generic sheet covering both.

A note on scope

Everything above describes categories of research compound and the mechanisms they engage in laboratory models. This is not a protocol, and it contains no doses or usage instructions. The point is simply to explain why these two families exist and why they are so often paired in the literature.

Sourcing the pairing in Canada

LYFE Science carries CJC-1295 (No DAC) together with Ipamorelin, the exact one-from-each combination the research literature is built around, supplied as a Canadian source. Each lot is verified by HPLC and mass spectrometry, with a certificate of analysis available for the lot you receive.

Every LYFE order ships Canada-wide by Canada Post with same-day dispatch when payment clears before noon ET, and most of the country receives it in one to three business days. Shipping is a flat $25, free once your cart passes $150, and every parcel goes out in plain, neutral packaging. We accept Interac e-Transfer and crypto (BTC, ETH, SOL, USDC, USDT), and every lot is verified by HPLC and mass spectrometry with a certificate of analysis available on request.

New to this class of compound? Start with the peptide guide, or see the wider range on the shop. The CJC-1295 and Ipamorelin pairing lives in our signalling research category.

Buy CJC-1295 + Ipamorelin in Canada